Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Libra

Showing results (241-250 of 280) with videos related to

Pageof 28
Sort By:
Cell Cycle (Georgetown, Tex.)|November 20, 2012
Ectopic NGAL expression can alter sensitivity of breast cancer cells to EGFR, Bcl-2, CaM-K inhibitors and the plant natural product berberineWilliam H Chappell, Stephen L Abrams, Richard A Franklin, et al.
Advances in Enzyme Regulation|July 21, 2006
Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistanceJames A McCubrey, Linda S Steelman, Steven L Abrams, et al.
Advances in Biological Regulation|July 8, 2018
Introduction of WT-TP53 into pancreatic cancer cells alters sensitivity to chemotherapeutic drugs, targeted therapeutics and nutraceuticalsStephen L Abrams, Kvin Lertpiriyapong, Li V Yang, et al.
Cells|April 30, 2021
GSK-3β Can Regulate the Sensitivity of MIA-PaCa-2 Pancreatic and MCF-7 Breast Cancer Cells to Chemotherapeutic Drugs, Targeted Therapeutics and NutraceuticalsStephen L Abrams, Shaw M Akula, Akshaya K Meher, et al.
Biochimica Et Biophysica Acta|November 28, 2006
Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistanceJames A McCubrey, Linda S Steelman, William H Chappell, et al.
Advances in Biological Regulation|August 11, 2020
Cancer therapy and treatments during COVID-19 eraShaw M Akula, Stephen L Abrams, Linda S Steelman, et al.
EMBO Molecular Medicine|April 24, 2013
Stathmin regulates mutant p53 stability and transcriptional activity in ovarian cancerMaura Sonego, Monica Schiappacassi, Sara Lovisa, et al.
Advances in Biological Regulation|February 28, 2018
Metformin influences drug sensitivity in pancreatic cancer cellsSaverio Candido, Stephen L Abrams, Linda Steelman, et al.
Advances in Biological Regulation|October 27, 2018
Abilities of berberine and chemically modified berberines to inhibit proliferation of pancreatic cancer cellsStephen L Abrams, Matilde Y Follo, Linda S Steelman, et al.
Biochimica Et Biophysica Acta|September 11, 2016
Effects of mutations in Wnt/β-catenin, hedgehog, Notch and PI3K pathways on GSK-3 activity-Diverse effects on cell growth, metabolism and cancerJames A McCubrey, Dariusz Rakus, Agnieszka Gizak, et al.
Pageof 28

Showing results (241-250 of 280) with videos related to

Sort By:
Pageof 28
Cell Cycle (Georgetown, Tex.)|November 20, 2012
Ectopic NGAL expression can alter sensitivity of breast cancer cells to EGFR, Bcl-2, CaM-K inhibitors and the plant natural product berberineWilliam H Chappell, Stephen L Abrams, Richard A Franklin, et al.
Advances in Enzyme Regulation|July 21, 2006
Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistanceJames A McCubrey, Linda S Steelman, Steven L Abrams, et al.
Advances in Biological Regulation|July 8, 2018
Introduction of WT-TP53 into pancreatic cancer cells alters sensitivity to chemotherapeutic drugs, targeted therapeutics and nutraceuticalsStephen L Abrams, Kvin Lertpiriyapong, Li V Yang, et al.
Cells|April 30, 2021
GSK-3β Can Regulate the Sensitivity of MIA-PaCa-2 Pancreatic and MCF-7 Breast Cancer Cells to Chemotherapeutic Drugs, Targeted Therapeutics and NutraceuticalsStephen L Abrams, Shaw M Akula, Akshaya K Meher, et al.
Biochimica Et Biophysica Acta|November 28, 2006
Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistanceJames A McCubrey, Linda S Steelman, William H Chappell, et al.
Advances in Biological Regulation|August 11, 2020
Cancer therapy and treatments during COVID-19 eraShaw M Akula, Stephen L Abrams, Linda S Steelman, et al.
EMBO Molecular Medicine|April 24, 2013
Stathmin regulates mutant p53 stability and transcriptional activity in ovarian cancerMaura Sonego, Monica Schiappacassi, Sara Lovisa, et al.
Advances in Biological Regulation|February 28, 2018
Metformin influences drug sensitivity in pancreatic cancer cellsSaverio Candido, Stephen L Abrams, Linda Steelman, et al.
Advances in Biological Regulation|October 27, 2018
Abilities of berberine and chemically modified berberines to inhibit proliferation of pancreatic cancer cellsStephen L Abrams, Matilde Y Follo, Linda S Steelman, et al.
Biochimica Et Biophysica Acta|September 11, 2016
Effects of mutations in Wnt/β-catenin, hedgehog, Notch and PI3K pathways on GSK-3 activity-Diverse effects on cell growth, metabolism and cancerJames A McCubrey, Dariusz Rakus, Agnieszka Gizak, et al.
Pageof 28